{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:25:10Z","timestamp":1790558710538,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF20H300011"],"award-info":[{"award-number":["LGF20H300011"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejps.2023.106530","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:04:28Z","timestamp":1689570268000},"page":"106530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Preparation of pazopanib-fumarate disodium glycyrrhizinate nanocrystalline micelles by liquid-assisted ball milling"],"prefix":"10.1016","volume":"188","author":[{"given":"Dan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106530_bib0001","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/cg3002948","article-title":"Polymorphs, salts, and cocrystalss: what's in a name","volume":"12","author":"Aitipamula","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2023.106530_bib0002","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1039\/b402150a","article-title":"Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines","author":"Almarsson","year":"2004","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejps.2023.106530_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10915810701351228","article-title":"Final report on the safety assessment of glycyrrhetinic acid, potassium glycyrrhetinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycyrrhizate","volume":"26","author":"Andersen","year":"2007","journal-title":"Int. J. Toxicol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106530_bib0004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/09546634.2015.1115817","article-title":"Induction therapy with a combination of fumarates and cyclosporine: a benefit for the patient?","volume":"27","author":"Arani","year":"2016","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.ejps.2023.106530_bib0005","first-page":"364","article-title":"Anthelmintic efficacy of supramolecular complex of praziquantel obtained by mechanochemical technology","volume":"15","author":"Arkhipov","year":"2020","journal-title":"Iran. J. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106530_bib0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijpharm.2015.07.075","article-title":"Novel self-assembled nano-tubular mixed micelles of pluronics p123, pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: in vitro characterization, ex vivo transport and in vivo pharmacokinetic studies","volume":"493","author":"Basalious","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2023.106530_bib0007","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/clpt.2012.73","article-title":"Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the achilles heel of targeted therapy","volume":"92","author":"Budha","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106530_bib0008","first-page":"1","article-title":"Harnessing soft tissue sarcoma with low-dose pazopanib\u2013a matter of blood levels","volume":"18","author":"Groenland","year":"2018","journal-title":"BioMedCentral Cancer"},{"issue":"1","key":"10.1016\/j.ejps.2023.106530_bib0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.04.037","article-title":"Solubility and bioavailability improvement of pazopanib hydrochloride","volume":"544","author":"Herbrink","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejps.2023.106530_bib0010","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1158\/1078-0432.CCR-08-2740","article-title":"Phase I trial of pazopanib in patients with advanced cancer","volume":"15","author":"Hurwitz","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ejps.2023.106530_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5173(99)00191-X","article-title":"Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique","volume":"187","author":"Jung","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106530_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.xphs.2021.08.008","article-title":"Towards virtual bioequivalence studies for oral dosage forms containing poorly water-soluble drugs: a physiologically based biopharmaceutics modeling (PBBM) approach","volume":"111","author":"Kambayashi","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"25","key":"10.1016\/j.ejps.2023.106530_bib0013","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1021\/jp711291x","article-title":"Vesicle-to-spherical micelle-to-tubular nanostructure transition of monomethoxy-poly (ethylene glycol) -poly (trimethylene carbonate) diblock copolymer","volume":"112","author":"Kim","year":"2008","journal-title":"J. Phys. Chem. B"},{"issue":"7","key":"10.1016\/j.ejps.2023.106530_bib0014","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1535-7163.MCT-07-0193","article-title":"Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity","volume":"6","author":"Kumar","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.ejps.2023.106530_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jat.3551","article-title":"Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines","volume":"38","author":"Mingard","year":"2018","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106530_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010060","article-title":"Relative dose intensity of induction-phase pazopanib treatment of soft tissue sarcoma: its relationship with prognoses of pazopanib responders","volume":"8","author":"Nakano","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejps.2023.106530_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ultsonch.2015.10.022","article-title":"Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug","volume":"29","author":"Pereira","year":"2016","journal-title":"Ultrason. Sonochem."},{"issue":"3","key":"10.1016\/j.ejps.2023.106530_bib0018","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinthera.2012.01.014","article-title":"Pazopanib for the treatment of metastatic renal cell carcinoma","volume":"34","author":"Pick","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2023.106530_bib0019","doi-asserted-by":"crossref","first-page":"101462","DOI":"10.1016\/j.jddst.2019.101462","article-title":"Aqueous solubility of kinase inhibitors: i the effect of hydrophilic polymers on their \u03b3-cyclodextrin solubilization","volume":"55","author":"Praphanwittaya","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"35","key":"10.1016\/j.ejps.2023.106530_bib0020","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1039\/D1CE00785H","article-title":"Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids","volume":"23","author":"Rai","year":"2021","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejps.2023.106530_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/17425247.2013.747508","article-title":"cocrystalslization for successful drug delivery","volume":"10","author":"Sun","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejps.2023.106530_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jcph.16","article-title":"Bayesian methods for pharmacokinetic\/pharmacodynamic modeling of pazopanib-induced increases in blood pressure and transaminases","volume":"53","author":"Suttle","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106530_bib0023","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/mp400601g","article-title":"Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships","volume":"11","author":"Swarnakar","year":"2014","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106530_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12951-021-00911-7","article-title":"Mechanochemical preparation of chrysomycin a self-micelle solid dispersion with improved solubility and enhanced oral bioavailability","volume":"19","author":"Xu","year":"2021","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.ejps.2023.106530_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10717544.2017.1422298","article-title":"Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:11:46Z","timestamp":1760530306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0928098723001604"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106530","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation of pazopanib-fumarate disodium glycyrrhizinate nanocrystalline micelles by liquid-assisted ball milling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106530"}}